Gynecology Clinical Trials

  • Abbvie M12-816 - Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids

  • Abbvie M12-817 - A Phase 3 Study to Evaluate the Efficacy and Safety of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women

  • Abbvie M14-702 - A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Estradiol/Norethindrone Acetate in Subjects with Moderate to Severe Endometriosis-Associated Pain (EAP)

  • Abbvie M16-283 - A Phase 3b Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women

  • Allergan CMO-US-WH-0444 - A Prospective, Non-Interventional/Observational Registry of US Uterine Fibroids Patients (Capture-US)

  • Bayer BAY 16953 - An Open-Label, Parallel-Group, Randomized, Multicenter Study to Assess the Safety and Efficacy of Vilaprisan In Subjects With Uterine Fibroids Versus Standard Of Care

  • Bayer BAY 18894 - An Open-Label, Non-Randomized, Prospective Observational Cohort Study to Assess Post-Procedural Outcomes In Two Cohorts of Women Who Chose To Undergo Either Hysteroscopic Sterilization (Essure®)or Laparoscopic Tubal Sterilization

  • Bayer ESSURE - A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test (Essure-NovaSure PAS)

  • BD Diagnostics BDS-USLHPV - Longitudinal Clinical Evaluation of the HPV Assay on the BD Viper LT System with Cervical Specimens

  • Endoceutics ERC-242 - Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double-Blind and Randomized Phase III Study of 24-Week Intravaginal Prasterone)

  • Novavax RSV-M-301 - A Phase 3, Randomized, Observer-Blind, Placebo-Controlled, Group-Sequential Study To Determine The Immunogenicity and Safety Of A Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum in Healthy Third-Trimester Pregnant Women; and Safety and Efficacy of Maternally Transferred Antibodies In Preventing RSV Disease In Their Infants

  • Pharmacosmos AS P-Monofer-IDA-03 - A Phase III, Randomized, Open-Label, Comparative Safety and Efficacy Trial of Intravenous Iron Isomaltoside (Monofer®) and Iron Sucrose In Subjects With Iron Deficiency Anemia Who Are Intolerant or Unresponsive to Oral Iron Therapy or In Whom the Hemoglobin Measurement in Investigators' Opinion Were Sufficiently Low as to Require Rapid Repletion of Iron Stores to Minimize the Risk of Receiving a Blood Transfusion

  • Roche cX8-HPV-435 - Clinical Performances of Cobas® HPV and CINtec®PLUS Cytology for Identification of High-grade Cervical Disease

  • Sequenom SQNM-T21-107 - Collection of Whole Blood Specimens from Pregnant Women at Increased Risk for Fetal Chromosomal Abnormality for Use in Development of a Noninvasive Prenatal Test in the Detection of the Relative Quantity of Chromosomal Material in Circulating Cell-Free DNA Extracted from Maternal Plasma



Mark Martens, M.D., Chairman of Obstetrics and Gynecology at Jersey Shore University Medical Center explains a study that will evaluate a new experimental test that may detect different types of HPV, a sexually transmitted infection that could lead to cervical cancer. For information and eligibility criteria, call 732-776-2953.